Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Patent
1989-05-18
1991-01-22
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
424550, 514183, 514764, 514765, A01N 6302, A01N 2700, A61K 31015
Patent
active
049869884
ABSTRACT:
The Indian Ocean sea hare Dolabella auricularia has been found to contain a new cell growth inhibitory and antineoplastic (P388 leukemia) cyclodepsipeptide designated dolastatin 13.sup.(1) and a companion substance dehydrodolastatin 13.sup.(2). A series of high field (400 MHz) 2D-NMR experiments including sequential analyses by HMBC and NOE techniques and tandem mass spectrometry provided structural determinations. Dolastatin 13 and dehydrodolastatin 13 represent a new class of cyclodepsipeptides. Pharmaceutical preparations and therapeutic regimens employing these new cytostatic depsipeptides are disclosed. The depsipeptides have the following structure: ##STR1##
REFERENCES:
patent: 4414205 (1983-11-01), Pettit
patent: 4486414 (1984-12-01), Pettit
patent: 4816444 (1989-03-01), Pettit et al.
"Isolation and Structure of the Cytostatic Depsipeptide Dolastatin 13 from the Sea Hare Dolabella auricularia", Pettit et al., J. Am. Chem. Soc., 1989, 111, 5015-5017.
Kamano Yoshiaki
Pettit George R.
Arizona Board of Regents
Azpuru C.
Cashion Jr. Merrell C.
Mybeck Richard R.
LandOfFree
Isolation and structural elucidation of the cytostatic linear de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation and structural elucidation of the cytostatic linear de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation and structural elucidation of the cytostatic linear de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1554179